Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandwich P-CHOP + RT in ENKTL
NCT02520479Phase 2Terminated
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2013
- Primary completion
- Dec 2017
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Sun Yat-sen University. Started Jun 2013; status: terminated.
02
Drugs
pegaspargase
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT02520479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520479.